AI/ML Innovations Inc. (CSE: AIML | OTCQB: AIMLF | FSE: 42FB) announced on November 17, 2026, that it has closed the first tranche of a non-brokered private placement, issuing 10,000,000 units at $0.05 per unit to raise gross proceeds of $500,000. The company intends to deploy the funds toward general working capital. Investors may be watching the offering closely, as a statutory hold period on all issued securities extends to March 18, 2027, with the possibility of further tranches remaining open.

Key Points

  • AI/ML Innovations Inc. (CSE: AIML, OTCQB: AIMLF, FSE: 42FB) is a Toronto-based digital health technology company.
  • The company closed the first tranche of a non-brokered private placement, raising gross proceeds of $500,000.
  • 10,000,000 units were issued at $0.05 each; each unit includes one common share and one warrant exercisable at $0.15 for 60 months.
  • All issued securities are subject to a statutory hold period expiring March 18, 2027.

Unit Structure and Warrant Terms in AIML's Private Placement

Each of the 10,000,000 units issued in the first tranche comprises one common share and one common share purchase warrant. Subject to the anti-dilution provisions contained in the warrant certificates, each warrant entitles the holder to acquire one additional common share at an exercise price of $0.15 for a period of 60 months from the date of issuance. If warrants are fully exercised, the offering would generate additional proceeds above the initial $500,000 raised, though the company did not disclose a projected total in the announcement.

Finder Fees and Broker Warrants Paid in Connection With the Offering

In connection with the first tranche, AI/ML Innovations paid eligible finders a cash fee of $14,000 and issued an aggregate of 280,000 broker warrants. Each broker warrant entitles the holder to acquire one common share at an exercise price of $0.15 for 60 months from the date of issuance, mirroring the terms of the standard unit warrants. The release states that these finders assisted in placing the offering, consistent with standard practice for non-brokered private placements in the Canadian junior capital markets.

Use of Proceeds and Hold Period for AIML Securities

The company states that net proceeds from the first tranche will be directed toward general working capital purposes. All securities issued and issuable in connection with the first tranche are subject to a statutory hold period expiring on March 18, 2027, meaning they cannot be freely traded until that date. The announcement notes that a further tranche of the offering remains possible, though no terms or closing timeline were confirmed. The immediate share price impact was not clear from available public information.